Can we predict cytomegalovirus reactivation in critically ill patients?

被引：1
作者：
Florescu, Diana F. [1 ]
Kalil, Andre C. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
CRITICAL CARE MEDICINE | 2012年 / 40卷 / 12期
关键词：
cytomegalovirus; interferon-gamma; sepsis; CELL TRANSPLANT RECIPIENTS; NATURAL-KILLER-CELLS; QUANTIFERON(R)-CMV; INFECTION; DISEASE;
D O I：
10.1097/CCM.0b013e31826563a4
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3313 / 3314
页数：2
相关论文
共 12 条
[1]   Human natural killer cells [J].
Caligiuri, Michael A. .
BLOOD, 2008, 112 (03) :461-469
[2]   Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients [J].
Chiche, Laurent ;
Forel, Jean-Marie ;
Thomas, Guillemette ;
Farnarier, Catherine ;
Cognet, Celine ;
Guervilly, Christophe ;
Zandotti, Christine ;
Vely, Frederic ;
Roch, Antoine ;
Vivier, Eric ;
Papazian, Laurent .
CRITICAL CARE MEDICINE, 2012, 40 (12) :3162-3169
[3]   Ex Vivo Monitoring of Human Cytomegalovirus-Specific CD8+ T-Cell Responses Using the QuantiFERON®-CMV Assay in Allogeneic Hematopoietic Stem Cell Transplant Recipients Attending an Irish Hospital [J].
Fleming, T. ;
Dunne, J. ;
Crowley, B. .
JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (03) :433-440
[4]   Medical progress: The pathophysiology and treatment of sepsis. [J].
Hotchkiss, RS ;
Karl, IE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) :138-150
[5]   Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit [J].
Kalil, Andre C. ;
Florescu, Diana F. .
CRITICAL CARE MEDICINE, 2009, 37 (08) :2350-2359
[6]   Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients [J].
Kumar, D. ;
Chernenko, S. ;
Moussa, G. ;
Cobos, I. ;
Manuel, O. ;
Preiksaitis, J. ;
Venkataraman, S. ;
Humar, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) :1214-1222
[7]   Regulatory NK-Cell Functions in Inflammation and Autoimmunity [J].
Luenemann, Anna ;
Luenemann, Jan D. ;
Muenz, Christian .
MOLECULAR MEDICINE, 2009, 15 (9-10) :352-358
[8]   Polyfunctional Cytomegalovirus-Specific CD4+and pp65 CD8+T Cells Protect Against High-Level Replication After Liver Transplantation [J].
Nebbia, G. ;
Mattes, F. M. ;
Smith, C. ;
Hainsworth, E. ;
Kopycinski, J. ;
Burroughs, A. ;
Griffiths, P. D. ;
Klenerman, P. ;
Emery, V. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (12) :2590-2599
[9]   Natural killer cells in human health and disease [J].
Orange, JS ;
Ballas, ZK .
CLINICAL IMMUNOLOGY, 2006, 118 (01) :1-10
[10]   Immunological Monitoring for Guidance of Preemptive Antiviral Therapy for Active Cytomegalovirus Infection in Allogeneic Stem-Cell Transplant Recipients: A Pilot Experience [J].
Solano, Carlos ;
Benet, Isabel ;
Jose Remigia, Maria ;
de la Camara, Rafael ;
Munoz-Cobo, Beatriz ;
Costa, Elisa ;
Angeles Clari, Maria ;
Bravo, Dayana ;
Amat, Paula ;
Navarro, David .
TRANSPLANTATION, 2011, 92 (04) :E17-E20
12